Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study.

Lesley F RobertsPascal LambertMark William Nachtigal Alon D AltmanErin Dean

Published in: Current oncology (Toronto, Ont.) (2024)

Our study demonstrated a high rate of chemotherapy dose reduction and discontinuation in the elderly epithelial ovarian cancer population. Further research is needed to identify risk factors for treatment discontinuation and intolerance in this population.

Keyphrases

middle aged
physical activity
type diabetes
metabolic syndrome
radiation therapy
combination therapy
locally advanced